scispace - formally typeset
Search or ask a question
Author

Peter J. Hotez

Baylor College of Medicine
Other affiliations: Rockefeller University, Texas Medical Center, Washington University in St. Louis  ...read more
Bio: Peter J. Hotez is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Neglected tropical diseases & Necator americanus. The author has an hindex of 99, co-authored 714 publications receiving 98372 citations. Previous affiliations of Peter J. Hotez include Rockefeller University & Texas Medical Center.
Topics: Neglected tropical diseases, Necator americanus, Global health, Hookworm vaccine, Population
Papers published on a yearly basis
Papers
More filters
Journal Article•DOI•
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

[...]

Rafael Lozano1, Mohsen Naghavi1, Kyle J Foreman2, Stephen S Lim1  +192 more•Institutions (95)
15 Dec 2012-The Lancet
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex, using the Cause of Death Ensemble model.

11,809 citations

Journal Article•DOI•
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

[...]

Theo Vos1, Amanuel Alemu Abajobir, Kalkidan Hassen Abate2, Cristiana Abbafati3  +775 more•Institutions (305)
16 Sep 2017-The Lancet
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.

10,401 citations

Journal Article•DOI•
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

[...]

Theo Vos, Abraham D. Flaxman1, Mohsen Naghavi1, Rafael Lozano1  +360 more•Institutions (143)
15 Dec 2012-The Lancet
TL;DR: Prevalence and severity of health loss were weakly correlated and age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010, but population growth and ageing have increased YLD numbers and crude rates over the past two decades.

7,021 citations

Journal Article•DOI•
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

[...]

Christopher J L Murray1, Theo Vos2, Rafael Lozano1, Mohsen Naghavi1  +366 more•Institutions (141)
15 Dec 2012-The Lancet
TL;DR: The results for 1990 and 2010 supersede all previously published Global Burden of Disease results and highlight the importance of understanding local burden of disease and setting goals and targets for the post-2015 agenda taking such patterns into account.

6,861 citations

Journal Article•DOI•
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

[...]

Mohsen Naghavi1, Haidong Wang1, Rafael Lozano1, Adrian Davis2  +728 more•Institutions (294)
10 Jan 2015-The Lancet
TL;DR: In the Global Burden of Disease Study 2013 (GBD 2013) as discussed by the authors, the authors used the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data.

5,792 citations

Cited by
More filters
疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A

[...]

宁北芳, 朱淮民
28 Jul 2005
TL;DR: PfPMP1）与感染红细胞、树突状组胞以及胎盘的单个或多个受体作用，在黏附及免疫逃避中起关键的作�ly.
Abstract: 抗原变异可使得多种致病微生物易于逃避宿主免疫应答。表达在感染红细胞表面的恶性疟原虫红细胞表面蛋白1（PfPMP1）与感染红细胞、内皮细胞、树突状细胞以及胎盘的单个或多个受体作用，在黏附及免疫逃避中起关键的作用。每个单倍体基因组var基因家族编码约60种成员，通过启动转录不同的var基因变异体为抗原变异提供了分子基础。

18,940 citations

Journal Article•DOI•
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

[...]

Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker, Héctor Bueno, John G.F. Cleland, Andrew J.S. Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A. Jankowska, Mariell Jessup, Cecilia Linde, Petros Nihoyannopoulos, John Parissis, Burkert Pieske, Jillian P. Riley, Giuseppe M.C. Rosano1, Luis M. Ruilope, Frank Ruschitzka, Frans H. Rutten, Peter van der Meer, Gerasimos Filippatos, John J.V. McMurray, Victor Aboyans, Stephan Achenbach, Stefan Agewall, Nawwar Al-Attar, John Atherton, Johann Bauersachs, A. John Camm, Scipione Carerj, Claudio Ceconi, Antonio Coca, Perry M. Elliott, Çetin Erol, Justin A. Ezekowitz, Covadonga Fernández-Golfín, Donna Fitzsimons, Marco Guazzi, Maxime Guenoun, Gerd Hasenfuss, Gerhard Hindricks, Arno W. Hoes, Bernard Iung, Tiny Jaarsma, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh2, Stavros Konstantinides, Mitja Lainscak, Patrizio Lancellotti2, Gregory Y.H. Lip, Francesco Maisano, Christian Mueller, Mark C. Petrie, Massimo F Piepoli, Silvia G. Priori, Adam Torbicki, Hiroyuki Tsutsui, Dirk J. van Veldhuisen, Stephan Windecker, Clyde W. Yancy, José Luis Zamorano •
St George's, University of London1, University of Liège2
01 Aug 2016-European Journal of Heart Failure
TL;DR: Authors/Task Force Members: Piotr Ponikowski* (Chairperson) (Poland), Adriaan A. Voors* (Co-Chair person) (The Netherlands), Stefan D. Anker (Germany), Héctor Bueno (Spain), John G. F. Cleland (UK), Andrew J. S. Coats (UK)

13,400 citations

Journal Article•DOI•
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

[...]

Rafael Lozano1, Mohsen Naghavi1, Kyle J Foreman2, Stephen S Lim1  +192 more•Institutions (95)
15 Dec 2012-The Lancet
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex, using the Cause of Death Ensemble model.

11,809 citations

Journal Article•DOI•
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

[...]

Theo Vos1, Amanuel Alemu Abajobir, Kalkidan Hassen Abate2, Cristiana Abbafati3  +775 more•Institutions (305)
16 Sep 2017-The Lancet
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.

10,401 citations

Journal Article•DOI•
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

[...]

Fernando P. Polack, Stephen J. Thomas1, Nicholas Kitchin2, Judith Absalon2, Alejandra Gurtman2, Stephen Lockhart2, John L. Perez2, Gonzalo Pérez Marc, Edson D. Moreira3, Cristiano Zerbini, Ruth Bailey2, Kena A. Swanson2, Satrajit Roychoudhury2, Kenneth Koury2, Ping Li2, Warren Kalina2, David A. Cooper2, Robert W. Frenck4, Laura L. Hammitt5, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal6, Dina B. Tresnan2, Susan Mather2, Philip R. Dormitzer2, Ugur Sahin, Kathrin U. Jansen2, William C. Gruber2 •
State University of New York Upstate Medical University1, Pfizer2, Oswaldo Cruz Foundation3, Cincinnati Children's Hospital Medical Center4, Johns Hopkins University5, Hacettepe University6
10 Dec 2020-The New England Journal of Medicine
TL;DR: A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older and safety over a median of 2 months was similar to that of other viral vaccines.
Abstract: Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a world...

10,274 citations